Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

In Vivo Enrichment of Genetically Manipulated Platelets for Murine Haemophilia B Gene Therapy

Yingyu Chen, PhD, Jocelyn A. Schroeder, Jianda Hu, PhD, Qizhen Shi, MD

Blood (2018) 132 (Supplement 1): 3483.

https://doi.org/10.1182/blood-2018-99-112245

Published: 2018

Journal Articles

Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells Following Autologous HSCT in Patients with B-NHL

Yang Cao, Na Wang, MD PhD, Gaoxiang Wang, MD PhD, Yi Xiao, MD PhD, Liang Huang, MD PhD, Chunrui Li, MD PhD, Min Xiao, MD PhD, Tongcun Zhang, PhD, Yicheng Zhang, MD PhD, Jianfeng Zhou, MD PhD

Blood (2018) 132 (Supplement 1): 2054.

https://doi.org/10.1182/blood-2018-99-113827

Published: 2018

Journal Articles

Egr-1, a Stress Response Transcription Factor and Myeloid Differentiation Primary Response Gene, Behaves As Tumor Suppressor in CML

Silvia Maifrede, PhDcandidate, Dan Liebermann, PhD, Barbara Hoffman, PhD

Blood (2014) 124 (21): 2211.

https://doi.org/10.1182/blood.V124.21.2211.2211

Published: 2014

Journal Articles

Stress Response Transcription Factor Egr-1 As Tumor Suppressor Of CML

Silvia Maifrede, PhD candidate, Dan Liebermann, Barbara Hoffman, PhD

Blood (2013) 122 (21): 4905.

https://doi.org/10.1182/blood.V122.21.4905.4905

Published: 2013

Journal Articles

In Vivo Selection Of Genetically Manipulated Hematopoietic Stem Cells For Platelet Gene Therapy Of Hemophilia A

Qizhen Shi, Jocelyn A. Schroeder, David A. Wilcox, Robert R. Montgomery, Yingyu Chen

Blood (2013) 122 (21): 2329.

https://doi.org/10.1182/blood.V122.21.2329.2329

Published: 2013

Journal Articles

Safety and Efficacy Of Lomustine (CCNU) Substituting Carmustine (BCNU) In Conditioning For Autologous Haematopoietic Stem Cell Transplantation In Lymphoma. A Retrospective Analysis Of Two Patient Cohorts Over a Ten Year Period

Sven Armin Sommerfeld, MRCP,, Samar Kulkarni, MD, MRCP, FRCPath, David Kaye, Adrian Bloor, PhD, FRCP, FRCPath

Blood (2013) 122 (21): 2127.

https://doi.org/10.1182/blood.V122.21.2127.2127

Published: 2013

Journal Articles

Baseline Characteristics and Symptom Burden in RESPONSE: A Randomized, Open-Label, Phase 3 Study of Ruxolitinib In Polycythemia Vera Patients Resistant to or Intolerant of Hydroxyurea

Alessandro M. Vannucchi, MD, Jean-Jacques Kiladjian, MD, PhD, Martin Griesshammer, Prof. Dr. med., Tamás Masszi, MD, PhD, Simon Durrant, MBBS, FRCP, FRCPath, Pierre Zachee, MD, PhD, Fabrizio Pane, MD, Claire N Harrison, DM, FRCP, FRCPath, Shui He, PhD, Lance Leopold, MD, Jingjin Li, Ulrich Pirron, PhD, Tomasz Lawniczek, MD, PhD, Srdan Verstovsek, MD, PhD

Blood (2013) 122 (21): 4071.

https://doi.org/10.1182/blood.V122.21.4071.4071

Published: 2013

Journal Articles

Fotemustine (MUFORAN) in Combination with Once Weekly Bortezomib and Dexamethasone (B-MuD): Good Clinical Activity and Favourable Toxicity Profile for Treatment of Relapsed Multiple Myeloma Patients.

Silvia Mangiacavalli, Alessandra Pompa, Lara Pochintesta, Cristiana Pascutto, Federica Cocito, MD, Mario Cazzola, Alessandro Corso

Blood (2012) 120 (21): 2957.

https://doi.org/10.1182/blood.V120.21.2957.2957

Published: 2012

Journal Articles

Stress Response Gene Egr-1 As Tumor Suppressor in BCR-ABL Mediated Leukemia

Silvia Maifrede, PhD candidate, Dan Liebermann, Barbara Hoffman, PhD

Blood (2012) 120 (21): 33.

https://doi.org/10.1182/blood.V120.21.33.33

Published: 2012

Journal Articles

A Novel DNM2 Mutation Displaying Embryonic Lethality and Impaired Transferrin Uptake Identified in a Mouse ENU Mutagenesis Screen for Genes Perturbing Erythropoiesis

Fiona C Brown, BSc, Michael Collett, BSc, Phillip J Robinson, PhD, James C Whisstock, PhD, Douglas J. Hilton, Benjamin T. Kile, Stephen M Jane, FRACP, FRCPA, MBBS, PhD, David J. Curtis, M.D., Ph.D.

Blood (2012) 120 (21): 608.

https://doi.org/10.1182/blood.V120.21.608.608

Published: 2012

Journal Articles

ENU Mutagenesis in the Mouse for Identification of Genes Regulating Erythropoiesis: a Mouse Mutant with An Activating Mutation of the KCl Cotransporter, KCC1 Causing Dehydrated Red Cells

David J. Curtis, MD, PhD, Fiona Brown, BSc, James Wiley, MD PhD, Shwen Ho, PhD, Douglas J. Hilton, PhD, Benjamin T. Kile, PhD, Stephen M Jane

Blood (2011) 118 (21): 684.

https://doi.org/10.1182/blood.V118.21.684.684

Published: 2011

Journal Articles

Coexistance of Multiple Myeloma and Myelodysplastic Syndrome or Lymphoid Diseases At Diagnosis: Evidence for Two Clonal and Independent Chromose Abnormalities

Hossein Mossafa, PhD, Sabine Defasque, Jr., MD, Christine Fourcade, Sr., JeanPierre Hurst, Sr., Bertrand Joly

Blood (2011) 118 (21): 5063.

https://doi.org/10.1182/blood.V118.21.5063.5063

Published: 2011

Journal Articles

The Xla (X-linked anemia) Mouse: A Transient Neonatal Anemia Caused by a Gata1 Splicing Mutation,

Kyle Miller, B.S., Michael Silvey, DO, Derek Logsdon, BS, Frederick Balch, BS, Ndona Nsumu, BS, MS, Inna Sokolovsky, MD, Margaret Gibson, BA, Chengpeng Bi, PhD, Daniel P. Heruth, PhD, Robert A White, PhD

Blood (2011) 118 (21): 3162.

https://doi.org/10.1182/blood.V118.21.3162.3162

Published: 2011

Journal Articles

Growth Factor Independent-1 (Gfi1) As a New Target for Human Leukemia Therapy

Cyrus Khandanpour, M.D., James D. Phelan, B.S., Riyan Chen, PhD., Shane Horman, PhD, Lothar Vassen, PhD, Marie-Claude Gaudreau, M.Sc., Joseph Krongold, BSc,, Jinfang Zhu, Ph.D., William E Paul, M.D., Judith Schütte, Berthold Goettgens, PhD., Ulrich Duehrsen, MD, H. Leighton Grimes, PhD, Tarik Moroy, Ph.D.

Blood (2011) 118 (21): 560.

https://doi.org/10.1182/blood.V118.21.560.560

Published: 2011

Journal Articles

Fotemustine IN COMBINATION with BORTEZOMIB and DEXAMETHASONE: Encouraging PRELIMINARY RESULTS FROM A PHASE II STUDY On Relapsed REFRACTORY MYELOMA PATIENTS

Alessandro Corso, MD, Silvia Mangiacavalli, MD, Federica Cocito, MD, Cristiana Pascutto, Cesare Astori, MD, Marzia Varettoni, MD, Ester Orlandi, MD, Patrizia Zappasodi, MD, Silvia Rizzi, MD, Ilaria Ambaglio, MD, Mario Lazzarino, Prof, Mario Cazzola, MD

Blood (2010) 116 (21): 3037.

https://doi.org/10.1182/blood.V116.21.3037.3037

Published: 2010

Journal Articles

Fludarabine, Cytarabine, Busulphan, and Cyclophosphamide (FABC) as Conditioning Regimen in Hematopoietic Stem Cell Transplantation for Treatment of 92 Patients with Hematologic Malignancies.

Jianyu Weng, MD, Xin Du, PhD, Suijin Wu, MD, Zesheng Lu, MD, Chengwei Luo, MD, Rong Guo, PhD, Liye Zhong, MD, Miaorong She, PhD, Chengxin Deng, Wei Ling, PhD, Xiaoli Zou, Qunhua Li, Wei Lin, Zhixin Huang

Blood (2009) 114 (22): 1147.

https://doi.org/10.1182/blood.V114.22.1147.1147

Published: 2009

Journal Articles

Use of MGMT Resistance to Enrich for Transduced Hematopoietic Cells in Gene Therapy for Fabry Disease.

Natalia A. Pacienza, PhD, Nobuo Mizue, PhD, Matthew Scaife, BSc, Ronan Foley, MD, FRCPC, Jeffrey A. Medin, PhD

Blood (2009) 114 (22): 3584.

https://doi.org/10.1182/blood.V114.22.3584.3584

Published: 2009

Journal Articles

Cytoreductive Regimen Containing Ranimustine (MCNU),Carboplatin, Etoposide and Cyclophosphamide (MCEC) Before Autologous Peripheral Blood Stem Cell Transplantation for Relapsed or Refractory Lymphoma

Yoshitaka Asakura, MD, Ryuji Tanosaki, MD, Sung-Won Kim, MD, Teruhisa Azuma, MD, Saiko Kurosawa, MD, Kimikazu Yakushijin, MD, Dai Maruyama, MD, Shin-ichiro Mori, MD, Takahiro Fukuda, MD, Takashi Watanabe, MD, Yukio Kobayashi, MD, PhD, Kensei Tobinai, MD, PhD, Yoichi Takaue, MD

Blood (2008) 112 (11): 4448.

https://doi.org/10.1182/blood.V112.11.4448.4448

Published: 2008

Journal Articles

A Novel Transcription Factor, zbtb11 Is Critical for Neutrophil Development in Zebrafish

Duncan Carradice, Judith E Layton, Joan K Heath, Graham J Lieschke

Blood (2008) 112 (11): 284.

https://doi.org/10.1182/blood.V112.11.284.284

Published: 2008

Journal Articles

Efficient Gene Marking with a Clinical Gammaretrovirus Vector Expressing MGMTP140K in Baboons and Macaques

Brian C Beard, PhD, Megan L Welsh, MS, Grant D Trobridge, PhD, Hans-Peter Kiem, MD

Blood (2008) 112 (11): 3535.

https://doi.org/10.1182/blood.V112.11.3535.3535

Published: 2008

NARROW

In Vivo Enrichment of Genetically Manipulated Platelets for Murine Haemophilia B Gene Therapy

Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells Following Autologous HSCT in Patients with B-NHL

Egr-1, a Stress Response Transcription Factor and Myeloid Differentiation Primary Response Gene, Behaves As Tumor Suppressor in CML

Stress Response Transcription Factor Egr-1 As Tumor Suppressor Of CML

In Vivo Selection Of Genetically Manipulated Hematopoietic Stem Cells For Platelet Gene Therapy Of Hemophilia A

Safety and Efficacy Of Lomustine (CCNU) Substituting Carmustine (BCNU) In Conditioning For Autologous Haematopoietic Stem Cell Transplantation In Lymphoma. A Retrospective Analysis Of Two Patient Cohorts Over a Ten Year Period

Baseline Characteristics and Symptom Burden in RESPONSE: A Randomized, Open-Label, Phase 3 Study of Ruxolitinib In Polycythemia Vera Patients Resistant to or Intolerant of Hydroxyurea

Fotemustine (MUFORAN) in Combination with Once Weekly Bortezomib and Dexamethasone (B-MuD): Good Clinical Activity and Favourable Toxicity Profile for Treatment of Relapsed Multiple Myeloma Patients.

Stress Response Gene Egr-1 As Tumor Suppressor in BCR-ABL Mediated Leukemia

A Novel DNM2 Mutation Displaying Embryonic Lethality and Impaired Transferrin Uptake Identified in a Mouse ENU Mutagenesis Screen for Genes Perturbing Erythropoiesis

ENU Mutagenesis in the Mouse for Identification of Genes Regulating Erythropoiesis: a Mouse Mutant with An Activating Mutation of the KCl Cotransporter, KCC1 Causing Dehydrated Red Cells

Coexistance of Multiple Myeloma and Myelodysplastic Syndrome or Lymphoid Diseases At Diagnosis: Evidence for Two Clonal and Independent Chromose Abnormalities

The Xla (X-linked anemia) Mouse: A Transient Neonatal Anemia Caused by a Gata1 Splicing Mutation,

Growth Factor Independent-1 (Gfi1) As a New Target for Human Leukemia Therapy

Fotemustine IN COMBINATION with BORTEZOMIB and DEXAMETHASONE: Encouraging PRELIMINARY RESULTS FROM A PHASE II STUDY On Relapsed REFRACTORY MYELOMA PATIENTS

Fludarabine, Cytarabine, Busulphan, and Cyclophosphamide (FABC) as Conditioning Regimen in Hematopoietic Stem Cell Transplantation for Treatment of 92 Patients with Hematologic Malignancies.

Use of MGMT Resistance to Enrich for Transduced Hematopoietic Cells in Gene Therapy for Fabry Disease.

Cytoreductive Regimen Containing Ranimustine (MCNU),Carboplatin, Etoposide and Cyclophosphamide (MCEC) Before Autologous Peripheral Blood Stem Cell Transplantation for Relapsed or Refractory Lymphoma

A Novel Transcription Factor, zbtb11 Is Critical for Neutrophil Development in Zebrafish

Efficient Gene Marking with a Clinical Gammaretrovirus Vector Expressing MGMTP140K in Baboons and Macaques

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only